Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB - Nasdaq - US7194051022 - Common Stock - Currency: USD

23.31  -0.2 (-0.85%)

After market: 23.31 0 (0%)

Fundamental Rating

6

Taking everything into account, PLAB scores 6 out of 10 in our fundamental rating. PLAB was compared to 109 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making PLAB a very profitable company, without any liquidiy or solvency issues. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make PLAB a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
PLAB had a positive operating cash flow in the past year.
Each year in the past 5 years PLAB has been profitable.
Each year in the past 5 years PLAB had a positive operating cash flow.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.63%, PLAB is in the better half of the industry, outperforming 71.30% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.66%, PLAB is in the better half of the industry, outperforming 71.30% of the companies in the same industry.
PLAB has a better Return On Invested Capital (10.75%) than 79.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PLAB is in line with the industry average of 11.96%.
Industry RankSector Rank
ROA 7.63%
ROE 11.66%
ROIC 10.75%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 15.07%, PLAB is in the better half of the industry, outperforming 71.30% of the companies in the same industry.
PLAB's Profit Margin has improved in the last couple of years.
PLAB's Operating Margin of 25.55% is amongst the best of the industry. PLAB outperforms 85.19% of its industry peers.
In the last couple of years the Operating Margin of PLAB has grown nicely.
With a Gross Margin value of 36.44%, PLAB is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 25.55%
PM (TTM) 15.07%
GM 36.44%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PLAB is destroying value.
Compared to 1 year ago, PLAB has more shares outstanding
Compared to 5 years ago, PLAB has less shares outstanding
The debt/assets ratio for PLAB has been reduced compared to a year ago.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

PLAB has an Altman-Z score of 3.53. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.53, PLAB perfoms like the industry average, outperforming 49.07% of the companies in the same industry.
The Debt to FCF ratio of PLAB is 0.14, which is an excellent value as it means it would take PLAB, only 0.14 years of fcf income to pay off all of its debts.
PLAB's Debt to FCF ratio of 0.14 is amongst the best of the industry. PLAB outperforms 86.11% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, PLAB is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Altman-Z 3.53
ROIC/WACC0.73
WACC14.74%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PLAB has a Current Ratio of 5.07. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.07, PLAB is doing good in the industry, outperforming 77.78% of the companies in the same industry.
A Quick Ratio of 4.76 indicates that PLAB has no problem at all paying its short term obligations.
The Quick ratio of PLAB (4.76) is better than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 4.76
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for PLAB have decreased by -2.94% in the last year.
PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.90% yearly.
The Revenue has decreased by -2.82% in the past year.
PLAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.50% yearly.
EPS 1Y (TTM)-2.94%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-18.06%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.13%

3.2 Future

PLAB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.85% yearly.
The Revenue is expected to grow by 6.61% on average over the next years.
EPS Next Y8.18%
EPS Next 2Y8.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.11%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.77, the valuation of PLAB can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 94.44% of the companies listed in the same industry.
PLAB is valuated cheaply when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
PLAB is valuated reasonably with a Price/Forward Earnings ratio of 10.88.
PLAB's Price/Forward Earnings ratio is rather cheap when compared to the industry. PLAB is cheaper than 94.44% of the companies in the same industry.
PLAB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.47.
Industry RankSector Rank
PE 11.77
Fwd PE 10.88
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

98.15% of the companies in the same industry are more expensive than PLAB, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 97.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.32
EV/EBITDA 2.71
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.44
PEG (5Y)0.35
EPS Next 2Y8.85%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (1/24/2025, 5:52:10 PM)

After market: 23.31 0 (0%)

23.31

-0.2 (-0.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-11 2024-12-11/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst Owners90.37%
Inst Owner Change-0.55%
Ins Owners3.84%
Ins Owner Change3.03%
Market Cap1.48B
Analysts82.86
Price Target35.7 (53.15%)
Short Float %3.86%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.26%
Min EPS beat(2)-10.71%
Max EPS beat(2)11.24%
EPS beat(4)1
Avg EPS beat(4)-8.42%
Min EPS beat(4)-17.55%
Max EPS beat(4)11.24%
EPS beat(8)3
Avg EPS beat(8)-2.29%
EPS beat(12)6
Avg EPS beat(12)5.04%
EPS beat(16)9
Avg EPS beat(16)6.61%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.07%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-4.86%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)6
Avg Revenue beat(12)-0.68%
Revenue beat(16)7
Avg Revenue beat(16)-0.55%
PT rev (1m)9.38%
PT rev (3m)9.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE 11.77
Fwd PE 10.88
P/S 1.7
P/FCF 11.32
P/OCF 5.65
P/B 1.32
P/tB 1.32
EV/EBITDA 2.71
EPS(TTM)1.98
EY8.49%
EPS(NY)2.14
Fwd EY9.19%
FCF(TTM)2.06
FCFY8.83%
OCF(TTM)4.13
OCFY17.71%
SpS13.69
BVpS17.7
TBVpS17.7
PEG (NY)1.44
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 7.63%
ROE 11.66%
ROCE 14.49%
ROIC 10.75%
ROICexc 18.5%
ROICexgc 18.5%
OM 25.55%
PM (TTM) 15.07%
GM 36.44%
FCFM 15.04%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Debt/EBITDA 0
Cap/Depr 158.24%
Cap/Sales 15.11%
Interest Coverage 250
Cash Conversion 85.91%
Profit Quality 99.79%
Current Ratio 5.07
Quick Ratio 4.76
Altman-Z 3.53
F-Score5
WACC14.74%
ROIC/WACC0.73
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.94%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-18.06%
EPS Next Y8.18%
EPS Next 2Y8.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.13%
Revenue Next Year6.11%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.47%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year43.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.63%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-13.48%
OCF growth 3Y20.13%
OCF growth 5Y30.76%